Medical Restrictions Sample Clauses

Medical Restrictions. An employee who is unable to perform the essential functions of their job classification due to work restrictions established by a medical professional will be removed from the standby schedule until the restrictions are lifted.
Sample 1Sample 2Sample 3See All (4)
AutoNDA by SimpleDocs
Medical Restrictions. 1. The Division Committee person and respective Supervisor or Manager shall agree upon the duties within the employee’s classification in which such restricted employee shall be able to perform consistent with medical restrictions and seniority. Should this create an excess, the least senior employee shall be excessed.
Sample 1Sample 2Sample 3
Medical Restrictions. When possible, HQ AMC TACC/XOGA will relay any altitude or flight restrictions due to medical reasons to the contractor's C2 agency at least 12 hours prior to flight departure. The MCD will also brief this information to the pilot in command prior to the flight.
Sample 1Sample 2
Medical Restrictions. 7 A unit member returning to work after a leave of absence with any 8 medical restrictions shall not resume his/her duties without clearance from 9 the Human Resources Office.
Sample 1
Medical Restrictions. (1) When an employee brings in a written restriction from their personal physician to their supervisor, the statement must be submitted to the Medical Department for determination. The Medical Department will evaluate and/or further investigate the restriction(s) to determine if the job complies with the restriction(s). A Fitness for Duty Evaluation may be scheduled pursuant to the ADAPT Procedure relative to the instant restriction(s). Upon issuance of a medical restriction(s) from the plant Medical Department, the employee shall be considered as a medically restricted employee for the purposes of this Medical Supplement. The plant Medical Department shall determine both the extent and duration of the medical restriction. Job Placement
Sample 1
Medical Restrictions. If the Employer places medical restrictions upon an employee, such restriction shall have a review date based upon severity. The length of time such restriction is imposed, as well as the review date, shall be at the discretion of the Employer. Upon written request of the employee, such restriction will be reviewed by the Employer within a reasonable time of the review date. If restrictions are imposed for periods longer than six (6) months, they will, upon written request of the employee, be reviewed by the Employer at intervals not to exceed six months. Exceptions to this review may be made by the Employer in those instances where restrictions are permanent. Notwithstanding any of the above, the Employer may, at anytime, review any restrictions imposed.
Sample 1
Medical Restrictions. An employee returning to work from absence due to a work-related injury must report back to work through the Company's Medical Department. The Medical Department will review the release from the employee's attending physician and will determine what temporary restrictions, if any, the employee has. If there are temporary restrictions placed on the employee, Medical will contact the employee's immediate supervisor or designated operations management to determine if the employee can be accepted with the restrictions. If the employee is unable to perform the essential functions of his job classification, the following provisions will apply. However, when an employee is unable to perform the essential functions of his job classification due to temporary medical restrictions, the employee may be assigned, at his current rate of pay including automatic progression raises, to other tasks outside his department within the restrictions of the employee’s functional capacity record. In determining other available jobs the parties shall first examine work within the employees occupation and then any other assignments the employee is capable of performing. The Company will make every effort to place the employee on his respective shift. Should it be necessary to move an employee between shifts, the move will be reviewed every ten (10) days for alternate placement or to place a less senior employee on restrictions in that position. The functions assigned will not be limited to duties covered by the Collective Bargaining Agreement. Such assignments will not result in those duties becoming bargaining unit work. Temporary medical assignments will not establish equity nor will it qualify the employee for that particular occupation. Employees performing such temporary medical assignments are not eligible for overtime. The Union will be provided a weekly list (by Name, Clock Number, Unit, Shift, and duties assigned) of employees assigned to such temporary medical assignments. Any concerns of placement will be immediately addressed upon request of the Union President. In the event a job cannot be found to accommodate the employee's restrictions, the employee will remain on workers’ compensation leave until he returns to work or eligible benefits are exhausted, whichever occurs first. Letter #21 INSPECTOR BONDING & ULTRASONICS (K-07) During the 2012 contract negotiations, the parties agreed to revise the Inspector Bonding & Ultrasonics (K-07) occupation job description. The rev...
Sample 1
AutoNDA by SimpleDocs
Medical Restrictions. An employee who has a medical restriction must provide to the Board a report from his/her physician outlining any restrictions, limitations and/or accommodations needed prior to reporting to his/her employment with his/her restrictions. The employee shall be required to provide updated medical reports at the request of the Superintendent.
Sample 1
Medical Restrictions. The arrangements for staff restricted by the Company Occupational Health Advisor from carrying out normal duties will be as follows:
Sample 1

Related to Medical Restrictions

  • General Restrictions The registered Holder of this Purchase Warrant agrees by his, her or its acceptance hereof, that such Holder will not: (a) sell, transfer, assign, pledge or hypothecate this Purchase Warrant for a period of one hundred eighty (180) days following the Effective Date to anyone other than: (i) Aegis Capital Corp. (“Aegis”) or an underwriter or a selected dealer participating in the Offering, or (ii) a bona fide officer or partner of Aegis or of any such underwriter or selected dealer, in each case in accordance with FINRA Conduct Rule 5110(g)(1), or (b) cause this Purchase Warrant or the securities issuable hereunder to be the subject of any hedging, short sale, derivative, put or call transaction that would result in the effective economic disposition of this Purchase Warrant or the securities hereunder, except as provided for in FINRA Rule 5110(g)(2). On and after 180 days after the Effective Date, transfers to others may be made subject to compliance with or exemptions from applicable securities laws. In order to make any permitted assignment, the Holder must deliver to the Company the assignment form attached hereto duly executed and completed, together with the Purchase Warrant and payment of all transfer taxes, if any, payable in connection therewith. The Company shall within five (5) Business Days transfer this Purchase Warrant on the books of the Company and shall execute and deliver a new Purchase Warrant or Purchase Warrants of like tenor to the appropriate assignee(s) expressly evidencing the right to purchase the aggregate number of Shares purchasable hereunder or such portion of such number as shall be contemplated by any such assignment.

  • General Restriction A Member may not Dispose of all or any portion of its Membership Interest except by complying with all of the following requirements:

  • Legal Restrictions 34.1 Without limiting the foregoing, Customer understands that laws regarding financial contracts vary throughout the world, and it is Customer's obligation alone to ensure that Customer fully complies with any law, regulation or directive, relevant to Customer's country of residency with regards to the use of the Web site.

  • Additional Restrictions In addition to any other restrictions on transfer contained in this Agreement, in no event may any Transfer of a Partnership Interest by any Partner or any redemption pursuant to Section 8.6 be made without the express consent of the General Partner, in its sole and absolute discretion, (i) to any person or entity who lacks the legal right, power or capacity to own a Partnership Interest; (ii) in violation of applicable law; (iii) of any component portion of a Partnership Interest, such as the Capital Account, or rights to distributions, separate and apart from all other components of a Partnership Interest; (iv) if in the opinion of the General Partner based on the advice of legal counsel, if appropriate, such Transfer would cause a termination of the Partnership for Federal or state income tax purposes (except as a result of a redemption of all Partnership Units held by all Limited Partners); (v) if in the opinion of the General Partner based on the advice of legal counsel, if appropriate, such Transfer would cause the Partnership to cease to be classified as a partnership for Federal income tax purposes (except as a result of a redemption of all Partnership Units held by all Limited Partners); (vi) if such Transfer requires the registration of such Partnership Interest pursuant to any applicable federal or state securities laws; (vii) if such Transfer would cause the Partnership to become a “publicly traded partnership,” as such term is defined in Section 7704(b) of the Code (provided that this clause (vii) shall not be the basis for limiting or restricting in any manner the exercise of the Redemption Right under Section 8.6 unless, and only to the extent that, outside tax counsel advises the General Partner that, in the absence of such limitation or restriction, there is a significant risk that the Partnership will be treated as a “publicly traded partnership” and, by reason thereof, taxable as a corporation); (viii) if such Transfer would cause the General Partner to own 10% or more of the ownership interests of any tenant of a property held by the Partnership within the meaning of Section 856(d)(2)(B) of the Code; (ix) if such Transfer would result in the General Partner being “closely held” within the meaning of Section 856(h) of the Code; or (x) if in the opinion the General Partner based on the advice of legal counsel, if appropriate, such Transfer would adversely affect the ability of the General Partner to continue to qualify as a REIT or subject the General Partner to any additional taxes under Section 857 or Section 4981 of the Code.

  • Basic Restrictions (i) (1) No Person, other than an Excepted Holder, shall Beneficially Own or Constructively Own Shares in excess of the Aggregate Ownership Limit, (2) no Person, other than an Excepted Holder, shall Beneficially Own or Constructively Own Common Shares in excess of the Common Share Ownership Limit and (3) no Excepted Holder shall Beneficially Own or Constructively Own Shares in excess of the Excepted Holder Limit for such Excepted Holder.

  • Activity Restrictions For so long as Investor or any of its Affiliates holds any Shares, neither Investor nor any Affiliate will: (1) vote any shares of Common Stock owned or controlled by it, sign or solicit any proxies, attend or be present at a shareholder meeting for purposes of determining a quorum, or seek to advise or influence any Person with respect to any voting securities of Company, except in accordance with the recommendation of Company’s board of directors; (2) engage or participate in any actions, plans or proposals which relate to or would result in (a) acquiring additional securities of Company, alone or together with any other Person, which would result in beneficially owning or controlling more than 9.99% of the total outstanding Common Stock or other voting securities of Company, (b) an extraordinary corporate transaction, such as a merger, reorganization or liquidation, involving Company or any of its Subsidiaries, (c) a sale or transfer of a material amount of assets of Company or any of its Subsidiaries, (d) any change in the present board of directors or management of Company, including any plans or proposals to change the number or term of directors or to fill any existing vacancies on the board, (e) any material change in the present capitalization or dividend policy of Company, (f) any other material change in Company’s business or corporate structure, including but not limited to, if Company is a registered closed-end investment company, any plans or proposals to make any changes in its investment policy for which a vote is required by Section 13 of the Investment Company Act of 1940, (g) changes in Company’s charter, bylaws or instruments corresponding thereto or other actions which may impede the acquisition of control of Company by any Person, (h) a class of securities of Company being delisted from a national securities exchange or to cease to be authorized to be quoted in an inter-dealer quotation system of a registered national securities association, (i) a class of equity securities of Company becoming eligible for termination of registration pursuant to Section 12(g)(4) of the Act, or (j) any action, intention, plan or arrangement similar to any of those enumerated above; or (3) request Company or its directors, officers, employees, agents or representatives to amend or waive any provision of this section.

  • Securities Law Restrictions In addition to any restrictions to be contained in that certain letter agreement (commonly known as an “Insider Letter”) to be dated as of the closing of the IPO by and between Subscriber and the Company, Subscriber agrees not to sell, transfer, pledge, hypothecate or otherwise dispose of all or any part of the Shares unless, prior thereto (a) a registration statement on the appropriate form under the Securities Act and applicable state securities laws with respect to the Shares proposed to be transferred shall then be effective or (b) the Company has received an opinion from counsel reasonably satisfactory to the Company, that such registration is not required because such transaction is exempt from registration under the Securities Act and the rules promulgated by the Securities and Exchange Commission thereunder and with all applicable state securities laws.

  • Definitional Restrictions Notwithstanding anything in this Agreement to the contrary, to the extent that any amount or benefit that would constitute non-exempt “deferred compensation” for purposes of Section 409A of the Code (“Non-Exempt Deferred Compensation”) would otherwise be payable or distributable hereunder, or a different form of payment of such Non-Exempt Deferred Compensation would be effected, by reason of a Change in Control or the Executive’s termination of employment, such Non-Exempt Deferred Compensation will not be payable or distributable to the Executive, and/or such different form of payment will not be effected, by reason of such circumstance unless the circumstances giving rise to such Change in Control or termination of employment, as the case may be, meet any description or definition of “change in control event” or “separation from service,” as the case may be, in Section 409A of the Code and applicable regulations (without giving effect to any elective provisions that may be available under such definition). This provision does not prohibit the vesting of any Non-Exempt Deferred Compensation upon a Change in Control or termination of employment, however defined. If this provision prevents the payment or distribution of any Non-Exempt Deferred Compensation, such payment or distribution shall be made on the date, if any, on which an event occurs that constitutes a Section 409A-compliant “change in control event” or “separation from service,” as the case may be, or such later date as may be required by subsection (c) below. If this provision prevents the application of a different form of payment of any amount or benefit, such payment shall be made in the same form as would have applied absent such designated event or circumstance.

  • Territorial Restrictions The Company is not restricted by any agreement or understanding with any other Person from carrying on its business anywhere in the world.

  • Xxxxxxx Xxxxxxx Restrictions/Market Abuse Laws The Participant acknowledges that, depending on his or her country, the broker’s country, or the country in which the Shares are listed, the Participant may be subject to xxxxxxx xxxxxxx restrictions and/or market abuse laws in applicable jurisdictions, which may affect his or her ability to accept, acquire, sell, or attempt to sell or otherwise dispose of Shares or rights to Shares (e.g., Special Retention Awards) or rights linked to the value of Shares, during such times as the Participant is considered to have “inside information” regarding the Company (as defined by applicable laws or regulations in the applicable jurisdictions, including the United States and the Participant’s country). Local xxxxxxx xxxxxxx laws and regulations may prohibit the cancellation or amendment of orders the Participant placed before possessing inside information. Furthermore, the Participant may be prohibited from (i) disclosing the inside information to any third party, including fellow employees (other than on a “need to know” basis) and (ii) “tipping” third parties or causing them to otherwise buy or sell securities. Any restrictions under these laws or regulations are separate from and in addition to any restrictions that may be imposed under any applicable Company xxxxxxx xxxxxxx policy. The Participant acknowledges that it is his or her responsibility to comply with any applicable restrictions, and the Participant should consult his or her personal advisor on this matter.

Time is Money Join Law Insider Premium to draft better contracts faster.